Answers are grounded in this paper and cite their sources.
Introduction: Toxoplasmosis infection is not transmitted from human to human, except in the case of transmission from mother to fetus, blood transfusion, or transplantation of an infected organ. The aim of this study was to compare the seroprevalence of toxoplasmosis in blood donors and patients with chronic renal failure (CRF) treated at the Ouakam Military Hospital (HMO). Methodology: We conducted a cross-sectional study between September and December 2022 among CRF patients followed up at the HMO and blood donors. A questionnaire was administered to collect socio-demographic information. A blood sample was then taken. Toxoplasma gondii IgG and IgM antibodies were tested by chemiluminescence. Data were analyzed using Epi Info 7.2.5.0 software. Results: A total of 200 participants were enrolled, including 100 volunteer blood donors and 100 hemodialysis patients. The mean ages were 30.7 ± 10 years and 41.4 ± 14.6 years for blood donors and CRF patients respectively. The overall seroprevalence of toxoplasmosis in blood donors was 33%, whereas it was 38% in CRF patients. IgM antibody positivity was noted in only one patient. Seroprevalence of toxoplasmosis in blood donors was highest in the 31-44 age group, at 37.5%, while in CRF patients it was highest in the over-45 age group, at 45.2%. According to the notion of contact with a cat, it was higher in hemodialysis patients who had been in contact with a cat, with a rate of 57.9% (p=0.047), in contrast to blood donors, where the highest rate was recorded in subjects who had not been in contact with a cat. Conclusion: This study revealed that the seroprevalence of toxoplasmosis was higher in CRF patients than in blood donors, with a seroprevalence rate higher than those previously reported in Dakar in pregnant women.
No takes yet. Share an insight, caveat, or question.
Seck et al. (2021) studied this question.
Synapse has enriched 8 related papers. Consider them for comparative context: